Tocilizumab cuts progression to ventilation or death in COVID-19
(HealthDay)—Tocilizumab reduces the risk for progression to ventilation or death among hospitalized patients with COVID-19 pneumonia, according to a study
Read more
(HealthDay)—Tocilizumab reduces the risk for progression to ventilation or death among hospitalized patients with COVID-19 pneumonia, according to a study
Read moreIn order to provide the best medical care for newly diagnosed Parkinson’s disease (PD) patients, a method of predicting their
Read moreDiet can have significant effects on the gut microbiome, the populations of microorganisms such as bacteria that live in the
Read moreALS researchers at the New York Genome Center (NYGC) have utilized new technologies for mapping gene expression in spinal cord
Read moreResearch into a new breakthrough therapy in the fight against sepsis has shown that the drug has potential to stop
Read moreAntidepressant could ‘improve old age for millions’ by slowing the progression of Alzheimer’s and Parkinson’s First human trails of drug trazodone’s
Read moreFRIDAY, Aug. 31, 2018 — In patients with progressive multiple sclerosis, slower progression of brain atrophy was seen with ibudilast
Read moreAn evolutionary model utilizing serial blood samples from patients with advanced colorectal cancer treated with anti-EGFR therapies in a phase
Read more